FDA of­fers sup­port for Pfiz­er, Mod­er­na Covid-19 vac­cines for the youngest chil­dren ahead of ad­comm

As the ma­jor­i­ty of par­ents of chil­dren un­der 12 who can be vac­ci­nat­ed against Covid-19 still de­cide against it — just 36% of 5-11 year-olds are vac­ci­nat­ed, ac­cord­ing to the AAP — the FDA over the past sev­er­al days laid out its case for why EUAs should be ex­pand­ed for both the Mod­er­na and Pfiz­er/BioN­Tech vac­cines to the youngest chil­dren of 6 months to 5 years.

The FDA’s VRB­PAC will meet to­mor­row and Wednes­day to re­view the lat­est da­ta and of­fer some per­spec­tive on the agency’s brief­ing doc­u­ments, which seem to sig­nal a like­ly EUA for both Mod­er­na and Pfiz­er/BioN­Tech in these pop­u­la­tions.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER